JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.95% |
| 2 | Technology | 12.9% |
| 3 | Financials | 12.36% |
| 4 | Healthcare | 9.31% |
| 5 | Consumer Discretionary | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
601
Lockheed Martin
LMT
$117B
| $124M | 0.02% |
344,926
+146,827
| +74% | +$49.1M |
2013 Q2
24 quarters
|
|
602
Aptiv
APTV
$9.04B
| $123M | 0.02% |
1,517,842
-1,980,685
| -57% | -$157M |
2013 Q2
24 quarters
|
|
|
DATA
603
DELISTED
Tableau Software, Inc.
DATA
| $123M | 0.02% |
747,177
+281,057
| +60% | +$36.9M |
2013 Q2
24 quarters
|
|
|
HZNP
604
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $122M | 0.02% |
5,090,627
+657,459
| +15% | +$16.7M |
2014 Q4
18 quarters
|
|
605
Stryker
SYK
$106B
| $122M | 0.02% |
604,357
+28,955
| +5% | +$5.53M |
2013 Q2
24 quarters
|
|
606
Q2 Holdings
QTWO
$3.52B
| $122M | 0.02% |
1,602,108
-109,299
| -6% | -$7.9M |
2014 Q2
20 quarters
|
|
|
AZPN
607
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $122M | 0.02% |
1,003,204
-96,200
| -9% | -$11.7M |
2013 Q2
24 quarters
|
|
608
American Tower
AMT
$75.6B
| $122M | 0.02% |
592,932
+203,595
| +52% | +$40.9M |
2013 Q2
24 quarters
|
|
609
Ciena
CIEN
$55.5B
| $122M | 0.02% |
2,929,324
+8,269
| +0.3% | +$318K |
2013 Q2
24 quarters
|
|
610
iShares 3-7 Year Treasury Bond ETF
IEI
$17.2B
| $121M | 0.02% |
961,749
+142,987
| +17% | +$17.7M |
2013 Q2
24 quarters
|
|
611
Iron Mountain
IRM
$33.8B
| $121M | 0.02% |
3,906,191
+990,959
| +34% | +$32.5M |
2013 Q2
24 quarters
|
|
612
Eversource Energy
ES
$24.3B
| $120M | 0.02% |
1,586,221
-181,556
| -10% | -$13.3M |
2013 Q2
24 quarters
|
|
613
PUT
UBS Group
UBS
$146B
| $120M | 0.02% |
10,095,100
+383,800
| +4% | +$4.7M |
2018 Q3
3 quarters
|
|
614
PUT
Simon Property Group
SPG
$65B
| $119M | 0.02% |
746,300
+389,400
| +109% | +$67.1M |
2019 Q1
1 quarter
|
|
615
HEICO Corp Class A
HEI.A
$31.4B
| $119M | 0.02% |
1,149,076
-136,276
| -11% | -$12.6M |
2016 Q2
12 quarters
|
|
616
iShares Biotechnology ETF
IBB
$10.5B
| $119M | 0.02% |
1,108,069
+604,388
| +120% | +$64.3M |
2013 Q2
24 quarters
|
|
617
Canadian Natural Resources
CNQ
$99.9B
| $119M | 0.02% |
9,047,108
+4,371,134
| +93% | +$60.1M |
2013 Q2
24 quarters
|
|
618
Zoetis
ZTS
$28.8B
| $119M | 0.02% |
1,053,879
+482,065
| +84% | +$50.5M |
2013 Q2
24 quarters
|
|
|
WORK
619
DELISTED
Slack Technologies, Inc.
WORK
| $119M | 0.02% |
+3,277,445
| New | +$121M |
2019 Q2
0 quarters
|
|
620
Brookfield
BN
$82.4B
| $118M | 0.02% |
6,943,339
+2,196,765
| +46% | +$37.2M |
2013 Q2
24 quarters
|
|
621
3M
MMM
$83.5B
| $118M | 0.02% |
822,390
-1,475,738
| -64% | -$227M |
2013 Q2
24 quarters
|
|
622
MKS Inc
MKSI
$18.9B
| $117M | 0.02% |
1,489,079
+274,145
| +23% | +$23.2M |
2013 Q2
24 quarters
|
|
623
Park Hotels & Resorts
PK
$3.13B
| $117M | 0.02% |
4,268,756
-2,499,424
| -37% | -$74.9M |
2017 Q1
9 quarters
|
|
624
Steris
STE
$20.3B
| $116M | 0.02% |
792,562
+493,578
| +165% | +$65.9M |
2014 Q4
18 quarters
|
|
625
Tesla
TSLA
$1.46T
| $116M | 0.02% |
7,802,115
-6,413,400
| -45% | -$99.8M |
2013 Q2
24 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,668 increased, 2,116 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.